HEMOGENYX PHARMPLC (Germany) Probability of Future Stock Price Finishing Over 132.46
| 5HU Stock | EUR 3.79 0.01 0.26% |
HEMOGENYX |
HEMOGENYX PHARMPLC Target Price Odds to finish over 132.46
The tendency of HEMOGENYX Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over € 132.46 or more in 90 days |
| 3.79 | 90 days | 132.46 | close to zero percent |
Based on a normal probability distribution, the odds of HEMOGENYX PHARMPLC to move over € 132.46 or more in 90 days from now is close to zero percent (This HEMOGENYX PHARMPLC LS 01 probability density function shows the probability of HEMOGENYX Stock to fall within a particular range of prices over 90 days) . Probability of HEMOGENYX PHARMPLC price to stay between its current price of € 3.79 and € 132.46 at the end of the 90-day period is about 41.75 .
Assuming the 90 days horizon HEMOGENYX PHARMPLC LS 01 has a beta of -25.68. This suggests as returns on its benchmark rise, returns on holding HEMOGENYX PHARMPLC LS 01 are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, HEMOGENYX PHARMPLC is expected to outperform its benchmark. In addition to that HEMOGENYX PHARMPLC LS 01 has an alpha of 34.2924, implying that it can generate a 34.29 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). HEMOGENYX PHARMPLC Price Density |
| Price |
Predictive Modules for HEMOGENYX PHARMPLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HEMOGENYX PHARMPLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.HEMOGENYX PHARMPLC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. HEMOGENYX PHARMPLC is not an exception. The market had few large corrections towards the HEMOGENYX PHARMPLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold HEMOGENYX PHARMPLC LS 01, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of HEMOGENYX PHARMPLC within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 34.29 | |
β | Beta against Dow Jones | -25.68 | |
σ | Overall volatility | 0.96 | |
Ir | Information ratio | 0.12 |
HEMOGENYX PHARMPLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HEMOGENYX PHARMPLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HEMOGENYX PHARMPLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HEMOGENYX PHARMPLC is way too risky over 90 days horizon | |
| HEMOGENYX PHARMPLC appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are owned by insiders or employees |
HEMOGENYX PHARMPLC Technical Analysis
HEMOGENYX PHARMPLC's future price can be derived by breaking down and analyzing its technical indicators over time. HEMOGENYX Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HEMOGENYX PHARMPLC LS 01. In general, you should focus on analyzing HEMOGENYX Stock price patterns and their correlations with different microeconomic environments and drivers.
HEMOGENYX PHARMPLC Predictive Forecast Models
HEMOGENYX PHARMPLC's time-series forecasting models is one of many HEMOGENYX PHARMPLC's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HEMOGENYX PHARMPLC's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about HEMOGENYX PHARMPLC
Checking the ongoing alerts about HEMOGENYX PHARMPLC for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HEMOGENYX PHARMPLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| HEMOGENYX PHARMPLC is way too risky over 90 days horizon | |
| HEMOGENYX PHARMPLC appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are owned by insiders or employees |
Other Information on Investing in HEMOGENYX Stock
HEMOGENYX PHARMPLC financial ratios help investors to determine whether HEMOGENYX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HEMOGENYX with respect to the benefits of owning HEMOGENYX PHARMPLC security.